Tango Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of TNGX for the last quarter is 11.61 M USD, and it's 41.60% lower compared to the previous quarter. The net income of Q3 24 is -29.17 M USD.